Search

Displaying results 9951 - 9960 of 10000 in total
  1. Drug

    PCI-27483

    go.drugbank.com/drugs/DB13000
    Investigational

    PCI-27483 has been used in trials studying the treatment of Pancreatic Cancer, Ductal Adrenocarcinoma, and Exocrine Pancreatic Cancer.

  2. Drug

    Tocladesine

    go.drugbank.com/drugs/DB13046
    Investigational

    Tocladesine has been used in trials studying the treatment of Colorectal Cancer and Multiple Myeloma and Plasma Cell Neoplasm.

  3. Drug

    Ceralasertib

    go.drugbank.com/drugs/DB14917
    Investigational

    Ceralasertib is under investigation in clinical trial NCT03682289 (Phase II Trial of AZD6738 Alone and in Combination With Olaparib).

  4. Drug

    Surufatinib

    go.drugbank.com/drugs/DB15106
    Investigational

    Surufatinib is under investigation in clinical trial NCT02588170 (Phase III Study of Surufatinib in Treating Advanced Extrapancreatic Neuroendocrine Tumors).

  5. Drug

    Olorofim

    go.drugbank.com/drugs/DB15245
    Investigational

    Olorofim is under investigation in clinical trial NCT03340597 (Assessment of Varying Oral Dosing Regimens for F901318 in Healthy Subjects).

  6. Drug

    Balixafortide

    go.drugbank.com/drugs/DB15370
    Investigational

    Balixafortide is under investigation in clinical trial NCT03786094 (Pivotal Study in HER2 Negative, Locally Recurrent or Metastatic Breast Cancer).

  7. Drug

    Ladiratuzumab vedotin

    go.drugbank.com/drugs/DB15409
    Investigational

    Ladiratuzumab vedotin is under investigation in clinical trial NCT01969643 (A Safety Study of SGN-LIV1A in Breast Cancer Patients).

  8. Drug

    PF-05105679

    go.drugbank.com/drugs/DB15450
    Investigational

    PF-05105679 is under investigation in clinical trial NCT01393652 (Single Dose, Dose Escalation Healthy Volunteers Study Of PF-05105679).

  9. Drug

    Farudodstat

    go.drugbank.com/drugs/DB16049
    Investigational

    Farudodstat (ASLAN003) is under investigation in clinical trial NCT03451084 (A Dose Optimisation Study of ASLAN003 in Acute Myeloid Leukemia).

  10. Drug

    ARRY-502

    go.drugbank.com/drugs/DB16053
    Investigational

    ARRY-502 is under investigation in clinical trial NCT01561690 (A Study of ARRY-502 in Patients With Persistent Asthma).